What is Moon Surgical?
Moon Surgical is at the forefront of advanced surgical technology, developing the AI-powered Maestro System. This innovative platform is engineered to establish a sustainable, efficient, and digitized operating room environment. By integrating robotic assistance with sophisticated software like Maestro Insights, the company aims to equip surgeons with enhanced control and actionable data, thereby improving surgical procedures. Moon Surgical's mission is to advance the art of surgery and improve global healthcare outcomes through teamwork and creativity, targeting healthcare professionals and institutions seeking cutting-edge solutions.
How much funding has Moon Surgical raised?
Moon Surgical has raised a total of $86.7M across 2 funding rounds:
Series A
$31.3M
Other Financing Round
$55.4M
Series A (2022): $31.3M with participation from Sofinnova Partners, Johnson & Johnson Innovation, Cathay Health, and GT Healthcare Capital & Partners
Other Financing Round (2023): $55.4M led by Sofinnova Partners and NVentures
Key Investors in Moon Surgical
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm specializing in life sciences and healthcare. They are known for their hands-on approach, acting as company builders across the entire value chain of life sciences investments, from seed to later stages.
Johnson & Johnson Innovation
Johnson & Johnson Innovation focuses on positively impacting human health through innovation, partnering with entrepreneurs and early-stage businesses to develop global healthcare solutions. They operate through a network of regional innovation centers, providing resources and collaborative approaches across multiple healthcare sectors.
NVentures
NVentures is an upstream exploration firm providing technical and commercial intelligence for the E&P and Energy industry, with a focus on subsurface context, renewables, and business development opportunities. They also offer detailed coverage of hydrogen and significant projects.
What's next for Moon Surgical?
The recent major strategic investment in Moon Surgical, following its Series A financing, suggests a pivotal growth phase for the company. This capital infusion is likely to accelerate the scaling of its Maestro System and expand its market reach within the healthcare sector. The company's focus on AI and robotic assistance in surgery positions it to capitalize on the increasing demand for digitalized and efficient operating rooms. Future developments may include further enhancements to the Maestro Insights software, broader adoption by medical institutions, and potential expansion into new surgical specialties, solidifying its role as a key innovator in surgical technology.
See full Moon Surgical company page
